["{\n\"step_by_step_thinking\": \"The question asks about the patient's suitability for exenatide. The relevant information is that the patient has type 1 diabetes mellitus, poor adherence to insulin therapy, and difficulty gaining weight despite eating copiously. We can rule out option D as exenatide is not contraindicated in children below 18 years. Option A does not seem relevant to the question as it only discusses the effectiveness of exenatide, but not its suitability for the patient. Option B seems more promising as it talks about hypoglycemia risk, which could be related to the patient's poor adherence to insulin therapy. Therefore, we need to examine the effects of exenatide on glucagon secretion.\n\nAccording to the provided documents, a case report suggests that the cause of alcohol-induced diabetes is probably due to impairment of insulin secretion by either alcohol itself or alcohol metabolites. This implies that in cases of impaired insulin production, such as type 1 diabetes mellitus, exenatide may not be effective. Additionally, the document does not mention any specific effects of exenatide on glucagon secretion.\n\nTherefore, we can conclude that the patient should not be switched to exenatide because their insulin production by the pancreas is insufficient for exenatide to be effective (option A).\",\n\"answer_choice\": A"]